发明名称 |
Modulation sAPP, sAPP alpha and BDNF levels in individuals diagnosed with FXS and ASD |
摘要 |
<p>A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting the amount of a therapeutic compound according to the plasma levels of BDNF, sAPP and sAPPs. In one embodiment, the therapeutic compound is acamprosate.</p> |
申请公布号 |
AU2013293167(A1) |
申请公布日期 |
2015.02.12 |
申请号 |
AU20130293167 |
申请日期 |
2013.07.22 |
申请人 |
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION |
发明人 |
ERICKSON, CRAIG A.;LAHIRI, DEBOMOY K. |
分类号 |
G01N33/53;A01N37/18;A01N43/54;A01N45/00;A61K31/35 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|